Nianguang Li

15PUBLICATIONS
10CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Haematological tumoursCheminformatics and quantitative structure-activity relationshipsBioinformatic methods development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 26, 2026
A Possibility of Synthetic Lethality: Wee1 Kinase as a Promising Treating Target for Cancer.

|May 23, 2026
Discovery of FYJ-195 as a Highly Potent FLT3 Inhibitor against Multiple Acquired Resistance Mutations in Acute Myeloid Leukemia.

|Apr 03, 2026
Discovery of FLC-8 as the First Covalent FLT3 Inhibitor Targeting Cys807 for FLT3 Mutant Acute Myeloid Leukemia.

Zi-Xuan Wang, Xiao-Long Jing, Qian Liu

|Feb 25, 2025
MALT1 Inhibitors and Degraders: Strategies for NF-κB-Driven Malignancies.

Ru-Yue Zhang, Zi-Xuan Wang, Meng-Yuan Zhang

|Feb 12, 2025
Metabolite Profiling of Danatinib in Mice Using Ultra-High-Performance Liquid Chromatography/Tandem Mass Spectrometry In Vitro and In Vivo.

Meng-Yuan Zhang, Yuan-Wei Zhang, Sheng-Nan Yu

|Dec 02, 2024
Kinase-Bench: Comprehensive Benchmarking Tools and Guidance for Achieving Selectivity in Kinase Drug Discovery.

Tian-Hua Wei, Shuang-Shuang Zhou, Xiao-Long Jing

Pageof 3

Frequent Collaborators

8 joint publications

Yan-Cheng Yu

7 joint publications

Xin Xue

4 joint publications

Xiao-Long Wang

3 joint publications

Shan-Liang Sun